Dysregulation of intestinal flora activates inflammatory pathways (e.g., NF-κB, TLR, and STAT3) and causes the release of bacterial toxins to accelerate the development of colon cancer. The gene discussed is NFKB1; the disease is malignant colon neoplasm.